As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including CLEAR Secure (NYSE:YOU) and its peers.
Organizations generate a lot of data that is stored in silos, often in incompatible formats, making it slow and costly to extract actionable insights, which in turn drives demand for modern cloud-based data analysis platforms that can efficiently analyze the siloed data.
The 7 data analytics stocks we track reported a strong Q4. As a group, revenues beat analysts’ consensus estimates by 2.3% while next quarter’s revenue guidance was in line.
Luckily, data analytics stocks have performed well with share prices up 11.3% on average since the latest earnings results.
CLEAR Secure (NYSE:YOU)
Recognized by its signature blue lanes and biometric pods at airport checkpoints across America, CLEAR Secure (NYSE:YOU) provides biometric identity verification technology that allows subscribers to bypass regular security lines at airports and access secure experiences at various venues.
CLEAR Secure reported revenues of $240.8 million, up 16.7% year on year. This print exceeded analysts’ expectations by 2.1%. Overall, it was an exceptional quarter for the company with a solid beat of analysts’ EBITDA and revenue estimates.
Interestingly, the stock is up 63.1% since reporting and currently trades at $54.60.
Best Q4: Palantir Technologies (NASDAQ:PLTR)
Named after the all-seeing stones in “Lord of the Rings,” Palantir Technologies (NASDAQ:PLTR) develops software platforms that help government agencies and enterprises integrate, analyze, and operationalize their data for decision-making.
Palantir Technologies reported revenues of $1.41 billion, up 70% year on year, outperforming analysts’ expectations by 4.9%. The business had a stunning quarter with a solid beat of analysts’ billings estimates and an impressive beat of analysts’ EBITDA estimates.
Palantir Technologies scored the fastest revenue growth among its peers. Although it had a fine quarter compared its peers, the market seems unhappy with the results as the stock is down 3.6% since reporting. It currently trades at $142.39.
Is now the time to buy Palantir Technologies? Access our full analysis of the earnings results here, it’s free.
Weakest Q4: Health Catalyst (NASDAQ:HCAT)
Built on its “Health Catalyst Flywheel” methodology that emphasizes measurable outcomes, Health Catalyst (NASDAQ:HCAT) provides data and analytics technology and services that help healthcare organizations manage their data and drive measurable clinical, financial, and operational improvements.
